A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

NCT01103050 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: QAV680 + Cetirizine Placebo
DRUG: QAV680 + Cetirizine
DRUG: Cetirizine + QAV680 Placebo
DRUG: QAV680 Placebo + Cetirizine Placebo

Sponsor

Novartis Pharmaceuticals